Correction to: Nature Medicine https://doi.org/10.1038/s41591-020-0938-9, published online 22 June 2020.
In the version of this article initially published, in the legend to Extended Data Fig. 9, Extended Data Fig. 3a,b was incorrectly identified as Supplementary Fig. 4a,b, and Extended Data Fig. 6a,b was incorrectly identified as Supplementary Fig. 8a,b. The correct section of that legend is as follows: “...tau burden from Extended Data Fig. 6a,b (respectively a, and b) but also oligomeric tau levels from Fig. 3a (respectively c, and d, p = 0.057) and 2 epitopes of tau hyperphosphorylation: PHF6, from Extended Data Fig. 3b (respectively e, and f, p = 0.051) and AT8 from Extended Data Fig. 3a (respectively g, and h)...”. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dujardin, S., Commins, C., Lathuiliere, A. et al. Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease. Nat Med 27, 356 (2021). https://doi.org/10.1038/s41591-021-01251-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-021-01251-7
This article is cited by
-
Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases
Neuroscience Bulletin (2023)
-
Biofluid Biomarkers of Alzheimer’s Disease: Progress, Problems, and Perspectives
Neuroscience Bulletin (2022)